These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 21670670)

  • 21. Cardiovascular disease in rheumatoid arthritis.
    Sen D; González-Mayda M; Brasington RD
    Rheum Dis Clin North Am; 2014 Feb; 40(1):27-49. PubMed ID: 24268008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects.
    Hurst S; Kallan MJ; Wolfe FJ; Fries JF; Albert DA
    J Rheumatol; 2002 Aug; 29(8):1639-45. PubMed ID: 12180722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives.
    Kitas GD; Gabriel SE
    Ann Rheum Dis; 2011 Jan; 70(1):8-14. PubMed ID: 21109513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions.
    Choy E; Sattar N
    Ann Rheum Dis; 2009 Apr; 68(4):460-9. PubMed ID: 19286905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory arthritis as a novel risk factor for cardiovascular disease.
    John H; Kitas G
    Eur J Intern Med; 2012 Oct; 23(7):575-9. PubMed ID: 22841864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of anti-malarials in rheumatoid arthritis--the American experience.
    Khraishi MM; Singh G
    Lupus; 1996 Jun; 5 Suppl 1():S41-4. PubMed ID: 8803910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy.
    Mäki-Petäjä KM; Hall FC; Booth AD; Wallace SM; Yasmin ; Bearcroft PW; Harish S; Furlong A; McEniery CM; Brown J; Wilkinson IB
    Circulation; 2006 Sep; 114(11):1185-92. PubMed ID: 16952987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular disease in rheumatoid arthritis: a step forward.
    Myasoedova E; Gabriel SE
    Curr Opin Rheumatol; 2010 May; 22(3):342-7. PubMed ID: 20164773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of physical inactivity with increased cardiovascular risk in patients with rheumatoid arthritis.
    Metsios GS; Stavropoulos-Kalinoglou A; Panoulas VF; Wilson M; Nevill AM; Koutedakis Y; Kitas GD
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):188-94. PubMed ID: 19238083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset.
    Wållberg-Jonsson S; Johansson H; Ohman ML; Rantapää-Dahlqvist S
    J Rheumatol; 1999 Dec; 26(12):2562-71. PubMed ID: 10606363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.
    Prodanovich S; Ma F; Taylor JR; Pezon C; Fasihi T; Kirsner RS
    J Am Acad Dermatol; 2005 Feb; 52(2):262-7. PubMed ID: 15692471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate.
    O'Dell JR; Haire C; Erikson N; Drymalski W; Palmer W; Maloley P; Klassen LW; Wees S; Moore GF
    J Rheumatol Suppl; 1996 Mar; 44():72-4. PubMed ID: 8833058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients.
    Morris SJ; Wasko MC; Antohe JL; Sartorius JA; Kirchner HL; Dancea S; Bili A
    Arthritis Care Res (Hoboken); 2011 Apr; 63(4):530-4. PubMed ID: 21452265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular risk and rheumatoid arthritis: from mechanisms of atherosclerosis to therapeutic approach.
    Jurcuţ C; Jurcuţ R; Tănăsescu C
    Rom J Intern Med; 2004; 42(4):659-69. PubMed ID: 16366138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rheumatoid arthritis and cardiovascular disease: an update on treatment issues.
    Barbhaiya M; Solomon DH
    Curr Opin Rheumatol; 2013 May; 25(3):317-24. PubMed ID: 23466960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular co-morbidity in early rheumatoid arthritis.
    John H; Kitas G; Toms T; Goodson N
    Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):71-82. PubMed ID: 19233047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Rheumatoid arthritis: a cardiovascular disease?].
    Daïen CI; Fesler P
    Ann Cardiol Angeiol (Paris); 2012 Apr; 61(2):111-7. PubMed ID: 21885031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis.
    Stavropoulos-Kalinoglou A; Metsios GS; Panoulas VF; Douglas KM; Nevill AM; Jamurtas AZ; Kita M; Koutedakis Y; Kitas GD
    Ann Rheum Dis; 2009 Feb; 68(2):242-5. PubMed ID: 18677010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple factors determine the increased prevalence of atherosclerosis in rheumatoid arthritis.
    Pereira IA; Borba EF
    Acta Reumatol Port; 2008; 33(1):47-55. PubMed ID: 18344921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cardiovascular comorbidity in rheumatic disease. Does sex play a role?].
    Kung M; Störk S; Angermann CE
    Herz; 2005 Sep; 30(6):512-21. PubMed ID: 16170682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.